These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29278738)

  • 1. Slowing disease progression in the SOD1 mouse model of ALS by blocking neuregulin-induced microglial activation.
    Liu J; Allender E; Wang J; Simpson EH; Loeb JA; Song F
    Neurobiol Dis; 2018 Mar; 111():118-126. PubMed ID: 29278738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1
    MacLean M; Juranek J; Cuddapah S; López-Díez R; Ruiz HH; Hu J; Frye L; Li H; Gugger PF; Schmidt AM
    J Neuroinflammation; 2021 Jun; 18(1):139. PubMed ID: 34130712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IRAK-M Plays A Role in the Pathology of Amyotrophic Lateral Sclerosis Through Suppressing the Activation of Microglia.
    Zhong X; Li C; Li Y; Huang Y; Liu J; Jiang A; Chen J; Peng Y
    Mol Neurobiol; 2024 Oct; 61(10):7603-7610. PubMed ID: 38421467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged NCX activation prevents SOD1 accumulation, reduces neuroinflammation, ameliorates motor behavior and prolongs survival in a ALS mouse model.
    Anzilotti S; Valsecchi V; Brancaccio P; Guida N; Laudati G; Tedeschi V; Petrozziello T; Frecentese F; Magli E; Hassler B; Cuomo O; Formisano L; Secondo A; Annunziato L; Pignataro G
    Neurobiol Dis; 2021 Nov; 159():105480. PubMed ID: 34411705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rutin Ameliorates ALS Pathology by Reducing SOD1 Aggregation and Neuroinflammation in an SOD1-G93A Mouse Model.
    Du X; Dong Q; Zhu J; Li L; Yu X; Liu R
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR inhibitor erlotinib delays disease progression but does not extend survival in the SOD1 mouse model of ALS.
    Le Pichon CE; Dominguez SL; Solanoy H; Ngu H; Lewin-Koh N; Chen M; Eastham-Anderson J; Watts R; Scearce-Levie K
    PLoS One; 2013; 8(4):e62342. PubMed ID: 23638043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
    Apolloni S; Fabbrizio P; Amadio S; Volonté C
    J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of methylene blue on microglia-induced inflammation and motor neuron degeneration in the SOD1(G93A) model for ALS.
    Dibaj P; Zschüntzsch J; Steffens H; Scheffel J; Göricke B; Weishaupt JH; Le Meur K; Kirchhoff F; Hanisch UK; Schomburg ED; Neusch C
    PLoS One; 2012; 7(8):e43963. PubMed ID: 22952827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cromolyn sodium delays disease onset and is neuroprotective in the SOD1
    Granucci EJ; Griciuc A; Mueller KA; Mills AN; Le H; Dios AM; McGinty D; Pereira J; Elmaleh D; Berry JD; Paganoni S; Cudkowicz ME; Tanzi RE; Sadri-Vakili G
    Sci Rep; 2019 Nov; 9(1):17728. PubMed ID: 31776380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
    Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
    Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minocycline delays disease onset and mortality in a transgenic model of ALS.
    Van Den Bosch L; Tilkin P; Lemmens G; Robberecht W
    Neuroreport; 2002 Jun; 13(8):1067-70. PubMed ID: 12060810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Oostveen JA; Gurney ME
    Glia; 1998 Jul; 23(3):249-56. PubMed ID: 9633809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.